NeuroPace (NPCE) Property, Plant & Equipment (Net) Growth (1y) (2021 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PP&E (Net) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 13.22% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 9.93% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 8.89% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 19.89% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 7.35% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 14.29% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 8.56% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 10.46% |
| 10 | NeuroPace | 558.86 Mn | 504.88 Mn | 18.05 Mn | 10.60% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10.60% |
| Dec 31, 2025 | 6.94% |
| Sep 30, 2025 | 6.44% |
| Jun 30, 2025 | 15.83% |
| Mar 31, 2025 | 10.69% |
| Dec 31, 2024 | 4.89% |
| Sep 30, 2024 | 9.69% |
| Jun 30, 2024 | 2.25% |
| Mar 31, 2024 | 2.34% |
| Dec 31, 2023 | -5.73% |
| Sep 30, 2023 | 6.15% |
| Jun 30, 2023 | 2.63% |
| Mar 31, 2023 | 19.07% |
| Dec 31, 2022 | 76.45% |
| Sep 30, 2022 | 43.27% |
| Jun 30, 2022 | 123.76% |
| Mar 31, 2022 | 80.67% |
| Dec 31, 2021 | 17.09% |